Jul 15, 2016 - Gilead (GILD) received a Notice of Compliance from Health Canada for Epclusa for the treatment of adults with genotype 1-6 chronic HCV infection.
May 05, 2016 - Merck & Co., Inc. (NYSE:MRK)Q1 2016 Earnings CallMay 05, 2016 8:00 am ETExecutivesTeri Loxam - Vice President, Investor RelationsKenneth C. Frazier - Chairman, President & Chief Executive OfficerRober
Feb 03, 2016 -
Sep 23, 2015 - Selloff in commodity, auto and biotech stocks dragged benchmarks lower on Tuesday
Sep 22, 2015 - ANI Pharmaceuticals (ANIP) announced that it has agreed to acquire two NDAs from Merck (MRK) for $75 million in cash and a percentage of future net sales.
Sep 22, 2015 - Inovio Pharmaceuticals, Inc. (INO) announced that the U.S. Defense Advanced Research Projects Agency has exercised its option to provide an additional $24 million for the development of Inovio's multiple treatment and prevention approaches against Ebola.
Sep 22, 2015 - Companies in the News are:
Sep 21, 2015 - Merck & Co. Inc. (MRK) announced encouraging data from two pivotal phase III clinical studies for its investigational antitoxin bezlotoxumab for prevention of recurrence of Clostridium difficile infection.
Sep 09, 2015 - Tetraphase Pharmaceuticals (TTPH) announced that the IGNITE2 study on eravacycline for complicated urinary tract infections did not meet its primary endpoint.
Sep 03, 2015 - Incyte (INCY) signs an agreement with Hengrui to develop and commercialize an anti-PD-1 monoclonal antibody, SHR-1210.